Getinge Value Stock - Dividend - Research Selection
Market price: 335,80 SEK
Getinge AB Series B Fundamental data and company key figures of the share
|Annual reports in SEK|
|Net operating cash flow||7.199.000.000|
|Free cash flow||6.761.999.872|
|Liabilities & Shareholders equity||45.014.000.000|
|Diluted shares outstanding||272.370.000|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Market Capitalization||10.314.043.392,00 USD|
|Indices||STOXX EUROPE 600|
|Sectors||Health Care Equipment|
|Raw Data Source||IFRS in Millionen SEK|
|Stock Split||2017-08-24,1399.000000/1379.000000; 2008-11-26,581.000000/570.000000; 2008-02-26,961.000000/947.000000; 2003-11-27,4.000000/1.000000|
Description of the company
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgery and life sciences in the hospital, pharmaceutical and research sectors. The company reports in three segments: Acute Therapies (63% of sales), Surgical Workflows (27%) and Life Sciences (10%). Product areas include ventilators, surgical stents, life support systems, sterilizers, operating tables and sterile transfer systems. Getinge generates its sales from a broad geographic presence, with the Americas accounting for 45% of sales (33% of sales in the US), 25% in the Asia-Pacific region and the remaining 30% in Europe, the Middle East and Africa.